Bentham Science Logo

Track Your Manuscript:

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 20, 10 Issues, 2021
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Subscribe to this Journal

Ranking and Category

  • 150th of 267 in


  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


CNS & Neurological Disorders - Drug Targets , Volume 17 - Number 1

Preface   Open Access

Commentary   Open Access

Commentary: Let the Time Fly: Dopamine is the Arbiter

, 17(1): 3 - 5

Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* and Ti-Fei Yuan*

DOI: 10.2174/1871527316999170505110106

Review Article

Antidepressant Potential of Peptides: New Insights as Future Therapeutic

, 17(1): 9 - 13

Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal

DOI: 10.2174/1871527316666170731102237

Review Article

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

, 17(1): 14 - 21

Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M. Hammad, Ahmed Menshawy and Wael M.Y. Mohamed

DOI: 10.2174/1871527316666170602101538

Review Article

VaD - An Integrated Framework for Cognitive Rehabilitation

, 17(1): 22 - 33

Maria Balea, Dafin Muresanu*, Anton Alvarez, Volker Homberg, Ovidiu Bajenaru, Alla Guekht, Wolf-Dieter Heiss, Livia Popa, Johannes Vester, Ioana Muresanu, Codruta Birle and Dana Slavoaca

DOI: 10.2174/1871527317666180219164545

Review Article

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models

, 17(1): 34 - 42

Ana Carolina Bombardi Duarte, Maycon Giovani Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi de Oliveira and Denise Goncalves Priolli*

DOI: 10.2174/1871527317666171221110139

Research Article

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

, 17(1): 43 - 53

Lupe C. Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria-Jose Fabrega and Ana C. Calpena

DOI: 10.2174/1871527317666180104122347

Research Article

In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

, 17(1): 54 - 68

Kanzal Iman, Muhammad Usman Mirza*, Nauman Mazhar, Michiel Vanmeert, Imran Irshad and Mohammad A. Kamal

DOI: 10.2174/1871527317666180115162422

Research Article

TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population

, 17(1): 69 - 74

Ada Sandoval-Carrillo, Cosme Alvarado-Esquivel, Carlos Salas-Martinez, Edna M. Mendez-Hernandez, Antonio Sifuentes-Alvarez, Ana L. Martínez-Martinez, Juan M. Castillo-Orona, Jesus Hernandez-Tinoco, Elizabeth I. Antuna-Salcido, Luis F. Sanchez-Anguiano, Lilia M. Velez Velez, Sergio M. Salas-Pacheco, Francisco X. Castellanos-Juarez, Osmel La Llave-Leon, Oscar Arias-Carrion* and Jose M. Salas-Pacheco*

DOI: 10.2174/1871527317666180207165238


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Related Journals

Related eBooks

eBooks Catalog